PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Leuprorelin acetate|DRUG: Letrozole|GENETIC: MammaPrint
Sponsor: Seoul National University Hospital